COVAX Global trial success!

Two-million doses of COVAX have been administered to Iranians participating in the COVAX trials, and the results have been extraordinary. Unlike the mRNA vaccines, there have been no adverse reactions and no one has suffered from myocarditis, pericarditis, blood clotting or any other vaccine Injury.

Help TheInformer at: